foxo4 dri senolytic FOXO4-DRI: Human Trial Status, Cancer Research & Data FOX04-DRI
FOX04 DRI FOXO4 DRI: A Breakthrough Peptide Targeting Aging at Its Roots PARTICLE, s. r. o. The FOXO4 peptide in a DRI conformation (D amino acids in a retro reversed sequence), henceforth named FOXO4 DRI, competes with FOXO4 for p53 binding in a dose dependent manner and doing so with higher affinity. Molecular targets of senolytic drugs. Download Scientific Diagram Class II senolytics inhibit survival pathways elicited by senescent Download Scientific Diagram
Pay in 4 interest-free payments of $7.31 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 17 - Sep 22

